Latest news
Loading news…
Evolyra Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. University Of Richmond, Virginia, United States For Profit
Evolyra Therapeutics develops next-generation AAV gene therapies for limb-girdle muscular dystrophy and other rare neuromuscular diseases.
BiopharmaBiotechnologyClinical TrialsGeneticsHealth CareMedicalNeurosciencePharmaceuticalTherapeutics
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 0
Company Info
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 4
- News articles
- 1
- HQ
- University Of Richmond, Virginia, United States
- Region
- East Coast, Southern US
Signals & Scores
- Heat score
- High
- Growth score
- High
- Trend (7d)
- 0.1
- Trend (30d)
- 1.4
- Trend (90d)
- 7.1
Key People at Evolyra Therapeutics
CTO & Co-Founder
COO & Co-Founder
Chief Science Officer & Co-Founder
CEO & Founder
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Evolyra Therapeutics
Loading news…
FAQs about Evolyra Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.